BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18580066)

  • 1. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation.
    Centeno F; Ramírez-Salazar E; García-Villa E; Gariglio P; Garrido E
    Intervirology; 2008; 51(2):137-43. PubMed ID: 18580066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
    Carrillo E; Garrido E; Gariglio P
    Intervirology; 2004; 47(6):342-9. PubMed ID: 15564746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of the transcription factor TAF1 is modified by the HPV16 E2 protein.
    Sánchez-Ramos J; Pozo-Molina G; Garrido E
    Acta Virol; 2020; 64(3):375-379. PubMed ID: 32985207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
    Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
    Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2.
    Okoye A; Cordano P; Taylor ER; Morgan IM; Everett R; Campo MS
    Virus Res; 2005 Mar; 108(1-2):1-14. PubMed ID: 15681049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.
    Hou SY; Wu SY; Zhou T; Thomas MC; Chiang CM
    Mol Cell Biol; 2000 Jan; 20(1):113-25. PubMed ID: 10594014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
    Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
    Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions.
    Cooper CS; Upmeyer SN; Winokur PL
    Virology; 1998 Feb; 241(2):312-22. PubMed ID: 9499806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
    Velazquez Torres A; Gariglio Vidal P
    Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome.
    Schmidt MT; Olejnik AK; Goździcka-Józefiak A
    Acta Biochim Pol; 2005; 52(4):823-32. PubMed ID: 16273126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction between human papillomavirus type 18 E2 and poly(ADP-ribose) polymerase 1.
    Lee D; Kim JW; Kim K; Joe CO; Schreiber V; Ménissier-De Murcia J; Choe J
    Oncogene; 2002 Aug; 21(38):5877-85. PubMed ID: 12185587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.
    Stubenrauch F; Zobel T; Iftner T
    J Virol; 2001 May; 75(9):4139-49. PubMed ID: 11287563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional characterization on the interaction of yeast TFIID subunit TAF1 with TATA-binding protein.
    Mal TK; Masutomi Y; Zheng L; Nakata Y; Ohta H; Nakatani Y; Kokubo T; Ikura M
    J Mol Biol; 2004 Jun; 339(4):681-93. PubMed ID: 15165843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRIP enhances HPV gene expression via interaction with either GR or E2.
    Chang SW; Lu PY; Guo JH; Tsai TC; Tsao YP; Chen SL
    Virology; 2012 Feb; 423(1):38-48. PubMed ID: 22177699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
    Thierry F; Howley PM
    New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of HPV16 early region transcription by the E2 protein.
    Soeda E; Ferran MC; Baker CC; McBride AA
    Virology; 2006 Jul; 351(1):29-41. PubMed ID: 16624362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
    Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
    Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces cerevisiae HMO1 interacts with TFIID and participates in start site selection by RNA polymerase II.
    Kasahara K; Ki S; Aoyama K; Takahashi H; Kokubo T
    Nucleic Acids Res; 2008 Mar; 36(4):1343-57. PubMed ID: 18187511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.
    Hegde RS; Androphy EJ
    J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.